Exon 14 splice mutation
|
MET
|
Non-Small Cell Lung Cancer (NSCLC)
|
Exon 17 mutations
|
KIT
|
Melanoma
|
Exon 19 deletion
|
EGFR
|
Non-Small Cell Lung Cancer (NSCLC)
|
Exon 19 insertion
|
EGFR
|
Non-Small Cell Lung Cancer (NSCLC)
|
Exon 20 insertion
|
EGFR
|
Non-Small Cell Lung Cancer (NSCLC)
|
Oncogenic Mutations
|
KRAS
|
Colorectal cancer, All solid tumors
|
Oncogenic Mutations
|
NRAS
|
Colorectal cancer, Melanoma
|
Oncogenic Mutations
|
ALK
|
NSCLC
|
Oncogenic Mutations
|
BRCA1
|
Breast Cancer (BC)
|
Oncogenic Mutations
|
BRCA2
|
BC
|
Oncogenic Mutations
|
ERBB2
|
BC, NSCLC
|
Oncogenic Mutations
|
FGFR2
|
All solid tumors
|
Oncogenic Mutations
|
FGFR3
|
All solid tumors
|
Oncogenic Mutations
|
KIT
|
Melanoma
|
Oncogenic Mutations
|
PIK3CA
|
BC
|
Oncogenic Mutations
|
TSC1
|
CNS
|
Oncogenic Mutations
|
TSC2
|
CNS
|
Oncogenic Mutations
|
ARAF
|
NSCLC
|
Oncogenic Mutations
|
ESR1
|
BC
|
Oncogenic Mutations
|
FGFR1
|
All solid tumors
|
Oncogenic Mutations
|
MAP2K1
|
Melanoma, NSCLC
|
Oncogenic Mutations
|
MTOR
|
All solid tumors
|
Oncogenic Mutations
|
ATM
|
All solid tumors
|
Oncogenic Mutations
|
CDKN2A
|
All solid tumors
|
Oncogenic Mutations
|
NF1
|
All solid tumors
|
Oncogenic Mutations
|
PTEN
|
All solid tumors
|
Oncogenic Mutations
|
SMARCB1
|
All solid tumors
|